Hamilton
Bermuda
266
2016-02-25
164
2016-04-05
These are the the leading inventors for applications assigned to IRM LLC:
IRM LLC based in Hamilton, BM has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
METHODS OF TREATING FGF21-ASSOCIATED DISORDERS
#2 | 2015-06-25 β Patent 9,303,034 granted on 2016-04-05Compounds and compositions for the treatment of parasitic diseases
#3 | 2015-05-07CANCER PATIENT SELECTION FOR ADMINISTRATION OF Wnt SIGNALING INHIBITORS USING RNF43 MUTATION STATUS
#4 | 2015-04-16SITE-SPECIFIC LABELING METHODS AND MOLECULES PRODUCED THEREBY
#5 | 2015-02-19COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS
#6 | 2015-01-08COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES
#7 | 2015-01-08COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS
#8 | 2015-01-01 β Patent 9,512,222 granted on 2016-12-06Lectin-like oxidized LDL receptor 1 antibodies and methods of use
#9 | 2014-10-30 β Patent 9,365,506 granted on 2016-06-14Compounds and compositions as TLR2 agonists
#10 | 2014-10-09 β Patent 9,624,520 granted on 2017-04-18Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
#11 | 2014-09-18 β Patent 9,296,754 granted on 2016-03-29Compounds and compositions for the treatment of parasitic diseases
#12 | 2014-09-18 β Patent 9,233,961 granted on 2016-01-12Compounds and compositions for the treatment of parasitic diseases
#13 | 2014-09-18 β Patent 9,186,361 granted on 2015-11-17Compounds and compositions for the treatment of parasitic diseases
#14 | 2014-09-18 β Patent 9,498,543 granted on 2016-11-22Antibody drug conjugates
#15 | 2014-09-11 β Patent 9,301,971 granted on 2016-04-05Peptides and compositions for treatment of joint damage
#16 | 2014-08-14 β Patent 9,023,839 granted on 2015-05-05Compounds and compositions as c-kit kinase inhibitors
#17 | 2014-07-24COMPOUNDS AND COMPOSITIONS AS PDGFR KINASE INHIBITORS
#18 | 2014-06-05 β Patent 8,871,754 granted on 2014-10-28Compounds and compositions for the treatment of parasitic diseases
#19 | 2014-04-24 β Patent 9,580,426 granted on 2017-02-28Compounds that expand hematopoietic stem cells
#20 | 2014-02-06 β Patent 9,592,288 granted on 2017-03-14Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
#21 | 2014-01-30 β Patent 8,754,071 granted on 2014-06-17Compounds and compositions as c-kit kinase inhibitors
#22 | 2014-01-09 β Patent 8,859,548 granted on 2014-10-14Compounds and compositions as protein kinase inhibitors
#23 | 2013-12-26COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS
#24 | 2013-12-12 β Patent 9,102,671 granted on 2015-08-11Compounds and compositions as TRK inhibitors
#25 | 2013-12-12 β Patent 9,150,568 granted on 2015-10-06Compositions and methods for modulating FXR
#26 | 2013-11-28PCSK9 ANTAGONISTS
#27 | 2013-11-21 β Patent 9,238,646 granted on 2016-01-19N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as WNT signaling modulators
#28 | 2013-11-21 β Patent 8,859,574 granted on 2014-10-14Compounds and compositions as kinase inhibitors
#29 | 2013-11-07 β Patent 8,703,787 granted on 2014-04-22Methods of using ALK inhibitors
#30 | 2013-10-17 β Patent 9,315,530 granted on 2016-04-19Adsorption of immunopotentiators to insoluble metal salts
#31 | 2013-10-03COMPOSITIONS AND METHODS FOR MODULATING FARNESOID X RECEPTORS
#32 | 2013-09-12 β Patent 8,883,819 granted on 2014-11-11Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
#33 | 2013-08-15METHODS AND COMPOSITIONS FOR TREATING CANCERS
#34 | 2013-08-15COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY
#35 | 2013-06-20Mechanically-Activated Cation Channels
#36 | 2013-05-23 β Patent 9,458,214 granted on 2016-10-04Dual function fibroblast growth factor 21 proteins
#37 | 2013-05-16 β Patent 9,597,326 granted on 2017-03-21Benzonapthyridine compositions and uses thereof
#38 | 2013-04-18COMPOUNDS AND METHODS FOR MODULATING G PROTEIN-COUPLED RECEPTORS
#39 | 2013-03-07 β Patent 9,199,981 granted on 2015-12-01Compounds and compositions as C-kit kinase inhibitors
#40 | 2013-03-07 β Patent 8,569,283 granted on 2013-10-29Compounds and compositions as c-Kit kinase inhibitors
#41 | 2013-01-03 β Patent 8,957,081 granted on 2015-02-17Compounds and compositions as protein kinase inhibitors
#42 | 2012-09-06 β Patent 8,563,553 granted on 2013-10-22Compounds and compositions as protein kinase inhibitors
#43 | 2012-09-06COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY
#44 | 2012-08-23 β Patent 8,569,345 granted on 2013-10-29Compounds and compositions as LXR modulators
#45 | 2012-08-09COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS
#46 | 2012-08-02COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS
#47 | 2012-08-02COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
#48 | 2012-07-12 β Patent 9,139,633 granted on 2015-09-22Mesenchymal stem cell differentiation
#49 | 2012-05-24 β Patent 9,023,791 granted on 2015-05-05Fibroblast growth factor 21 mutations
#50 | 2012-03-29COMPOSITIONS AND METHODS FOR MODULATING RETINOL BINDING TO RETINOL BINDING PROTEIN 4 (RBP4)
#51 | 2012-03-15 β Patent 8,637,516 granted on 2014-01-28Compounds and compositions as TRK inhibitors
#52 | 2012-02-02METHODS AND COMPOSITIONS FOR TREATING ALLERGIC DISEASES
#53 | 2011-12-15 β Patent 8,501,758 granted on 2013-08-06Compounds and compositions as protein kinase inhibitors
#54 | 2011-12-08 β Patent 8,293,757 granted on 2012-10-235-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
#55 | 2011-10-27COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS
#56 | 2011-10-27COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
#57 | 2011-10-20 β Patent 8,377,921 granted on 2013-02-19Compounds and compositions as protein kinase inhibitors
#58 | 2011-10-20 β Patent 8,399,450 granted on 2013-03-19Compounds and compositions as protein kinase inhibitors
#59 | 2011-10-20 β Patent 8,338,469 granted on 2012-12-25Compounds and compositions as channel activating protease inhibitors
#60 | 2011-10-06 β Patent 8,268,996 granted on 2012-09-18Compounds and compositions as cathepsin S inhibitors
#61 | 2011-10-06 β Patent 8,575,168 granted on 2013-11-05Compounds and compositions as modulators of GPR119 activity
#62 | 2011-10-06 β Patent 8,497,075 granted on 2013-07-30Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands
#63 | 2011-09-29 β Patent 8,546,396 granted on 2013-10-01N-(hetero)aryl, 2-(hetero)arylβsubstituted acetamides for use as Wnt signaling modulators
#64 | 2011-09-15 β Patent 8,258,156 granted on 2012-09-04Compounds and compositions as modulators of GPR119 activity
#65 | 2011-08-04 β Patent 8,334,288 granted on 2012-12-184-phenoxymethylpiperidines as modulators of GPR119 activity
#66 | 2011-08-04 β Patent 8,518,931 granted on 2013-08-27Compounds and compositions as kinase inhibitors
#67 | 2011-08-04COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
#68 | 2011-08-04 β Patent 8,372,858 granted on 2013-02-12Compounds and compositions as protein kinase inhibitors
#69 | 2011-07-28 β Patent 8,278,452 granted on 2012-10-02Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitors
#70 | 2011-07-21COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS
#71 | 2011-07-14 β Patent 8,362,050 granted on 2013-01-29Compounds and methods for modulating G protein-coupled receptors
#72 | 2011-07-14COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
#73 | 2011-07-07COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
#74 | 2011-07-07 β Patent 8,507,488 granted on 2013-08-13Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
#75 | 2011-06-30ANTAGONISTS OF PROTEASE ACTIVATED RECEPTOR-1 (PAR1)
#76 | 2011-06-23 β Patent 8,507,491 granted on 2013-08-13Compounds and compositions as hedgehog pathway inhibitors
#77 | 2011-06-16COMPOUNDS AND COMPOSITIONS USEFUL FOR THE TREATMENT OF MALARIA
#78 | 2011-06-16 β Patent 8,710,192 granted on 2014-04-29PCSK9 antagonists
#79 | 2011-06-09 β Patent 8,592,432 granted on 2013-11-26Compounds and compositions as protein kinase inhibitors
#80 | 2011-05-12 β Patent 8,445,505 granted on 2013-05-21Pyrimidine derivatives as kinase inhibitors
#81 | 2011-05-12 β Patent 8,519,129 granted on 2013-08-27Pyrimidine derivatives as kinase inhibitors
#82 | 2011-04-282,4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS
#83 | 2011-04-28 β Patent 8,642,035 granted on 2014-02-04Anti-TrkB antibodies
#84 | 2011-04-07 β Patent 8,466,167 granted on 2013-06-18Compounds and compositions as TLR activity modulators
#85 | 2011-03-10 β Patent 8,557,801 granted on 2013-10-15Compounds and compositions useful for the treatment of parasitic diseases
#86 | 2011-03-03 β Patent 8,288,540 granted on 2012-10-162-heteroarylamino-pyrimidine derivatives as kinase inhibitors
#87 | 2011-03-03COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS
#88 | 2011-03-03 β Patent 9,045,470 granted on 2015-06-02Compounds and compositions as TLR activity modulators
#89 | 2011-02-24METHODS AND COMPOSITIONS FOR TREATING LYMPHOMA AND MYELOMA
#90 | 2011-01-27COMPOSITIONS AND METHODS FOR TREATING CANCERS
#91 | 2011-01-06 β Patent 8,546,370 granted on 2013-10-01Compounds and compositions as kinase inhibitors
#92 | 2011-01-06 β Patent 8,354,526 granted on 2013-01-15Pyrido [4, 3-D] pyrimidinone derivatives as kinase inhibitors
#93 | 2010-12-30ANTAGONIST ANTIBODIES OF PROTEASE ACTIVATED RECEPTOR-1 (PAR1)
#94 | 2010-12-23 β Patent 8,592,433 granted on 2013-11-26Compounds and compositions as protein kinase inhibitors
#95 | 2010-11-25 β Patent 8,440,681 granted on 2013-05-142-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
#96 | 2010-09-23COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS
#97 | 2010-09-16 β Patent 8,338,417 granted on 2012-12-25Compounds and compositions as c-kit and PDGFR kinase inhibitors
#98 | 2010-09-16COMPOUNDS THAT MAINTAIN PLURIPOTENCY OF EMBRYONIC STEM CELLS
#99 | 2010-09-16 β Patent 8,431,607 granted on 2013-04-30Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
#100 | 2010-08-12INHIBITORS OF CATHEPSIN S
Also check out IRM LLC's (Hamilton, Bermuda) applicant profile with 1 patent applications submitted.
1955 β